Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 6.54690656 |
2 | translational termination (GO:0006415) | 6.40287810 |
3 | ribosomal small subunit assembly (GO:0000028) | 6.01568407 |
4 | translational elongation (GO:0006414) | 5.81373402 |
5 | ribosomal small subunit biogenesis (GO:0042274) | 5.67434372 |
6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.60348243 |
7 | protein targeting to ER (GO:0045047) | 5.48146447 |
8 | cotranslational protein targeting to membrane (GO:0006613) | 5.47266058 |
9 | maturation of SSU-rRNA (GO:0030490) | 5.44517482 |
10 | translational initiation (GO:0006413) | 5.41667887 |
11 | ribosomal large subunit biogenesis (GO:0042273) | 5.39785272 |
12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.21955396 |
13 | protein localization to endoplasmic reticulum (GO:0070972) | 5.17219386 |
14 | DNA deamination (GO:0045006) | 5.14207899 |
15 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.07593858 |
16 | viral life cycle (GO:0019058) | 5.03137734 |
17 | cellular protein complex disassembly (GO:0043624) | 5.00398995 |
18 | formation of translation preinitiation complex (GO:0001731) | 5.00039476 |
19 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.51407392 |
20 | proteasome assembly (GO:0043248) | 4.47041438 |
21 | translation (GO:0006412) | 4.43820895 |
22 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.40750340 |
23 | protein complex disassembly (GO:0043241) | 4.38599626 |
24 | macromolecular complex disassembly (GO:0032984) | 4.17866518 |
25 | ribosome assembly (GO:0042255) | 4.10024249 |
26 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.99067451 |
27 | chaperone-mediated protein transport (GO:0072321) | 3.98126746 |
28 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.89339918 |
29 | nucleobase biosynthetic process (GO:0046112) | 3.86379397 |
30 | ribosome biogenesis (GO:0042254) | 3.85145881 |
31 | purine nucleobase biosynthetic process (GO:0009113) | 3.78602288 |
32 | spliceosomal snRNP assembly (GO:0000387) | 3.75177850 |
33 | DNA strand elongation (GO:0022616) | 3.73045405 |
34 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.70739965 |
35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.69830429 |
36 | folic acid metabolic process (GO:0046655) | 3.69235709 |
37 | protein targeting to membrane (GO:0006612) | 3.68972795 |
38 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.66543123 |
39 | rRNA processing (GO:0006364) | 3.64562770 |
40 | respiratory electron transport chain (GO:0022904) | 3.64166421 |
41 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.63714234 |
42 | cellular component biogenesis (GO:0044085) | 3.61406640 |
43 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.57473111 |
44 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.57281569 |
45 | electron transport chain (GO:0022900) | 3.56192102 |
46 | * negative regulation of ligase activity (GO:0051352) | 3.55509962 |
47 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.55509962 |
48 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53907528 |
49 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.53266694 |
50 | DNA unwinding involved in DNA replication (GO:0006268) | 3.51904443 |
51 | * positive regulation of cell cycle arrest (GO:0071158) | 3.51882549 |
52 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.51495329 |
53 | DNA replication initiation (GO:0006270) | 3.51315817 |
54 | rRNA metabolic process (GO:0016072) | 3.49547099 |
55 | protein targeting to mitochondrion (GO:0006626) | 3.49461060 |
56 | DNA replication checkpoint (GO:0000076) | 3.44728300 |
57 | * regulation of cellular amino acid metabolic process (GO:0006521) | 3.44134934 |
58 | * regulation of cellular amine metabolic process (GO:0033238) | 3.43144716 |
59 | mRNA catabolic process (GO:0006402) | 3.41037216 |
60 | pseudouridine synthesis (GO:0001522) | 3.40990036 |
61 | inner mitochondrial membrane organization (GO:0007007) | 3.38890208 |
62 | regulation of mitochondrial translation (GO:0070129) | 3.38843271 |
63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.38232127 |
64 | ATP synthesis coupled proton transport (GO:0015986) | 3.38232127 |
65 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.37246633 |
66 | respiratory chain complex IV assembly (GO:0008535) | 3.37002486 |
67 | rRNA methylation (GO:0031167) | 3.36221880 |
68 | * negative regulation of protein ubiquitination (GO:0031397) | 3.33946851 |
69 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.31213213 |
70 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.30163939 |
71 | * cell cycle G1/S phase transition (GO:0044843) | 3.28523556 |
72 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.28523556 |
73 | RNA catabolic process (GO:0006401) | 3.28488720 |
74 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26197847 |
75 | chromatin remodeling at centromere (GO:0031055) | 3.24929374 |
76 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.23025095 |
77 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.23025095 |
78 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.21984698 |
79 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.21984698 |
80 | CENP-A containing nucleosome assembly (GO:0034080) | 3.21927971 |
81 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.21792033 |
82 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.21240375 |
83 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.21240375 |
84 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.21240375 |
85 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.19862230 |
86 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.19218662 |
87 | * positive regulation of ligase activity (GO:0051351) | 3.17991943 |
88 | protein complex biogenesis (GO:0070271) | 3.17102004 |
89 | IMP biosynthetic process (GO:0006188) | 3.16775174 |
90 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.15698629 |
91 | protein K6-linked ubiquitination (GO:0085020) | 3.15385216 |
92 | termination of RNA polymerase III transcription (GO:0006386) | 3.14507563 |
93 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.14507563 |
94 | protein localization to mitochondrion (GO:0070585) | 3.14380237 |
95 | * signal transduction in response to DNA damage (GO:0042770) | 3.11250318 |
96 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.10785716 |
97 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.10785716 |
98 | spliceosomal complex assembly (GO:0000245) | 3.09977543 |
99 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.08997759 |
100 | rRNA modification (GO:0000154) | 3.07208868 |
101 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.02548587 |
102 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.02377615 |
103 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.02149245 |
104 | glycine metabolic process (GO:0006544) | 3.01947131 |
105 | cytochrome complex assembly (GO:0017004) | 3.01854237 |
106 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.00418162 |
107 | cullin deneddylation (GO:0010388) | 2.99682655 |
108 | amino acid activation (GO:0043038) | 2.99407946 |
109 | tRNA aminoacylation (GO:0043039) | 2.99407946 |
110 | * regulation of cell cycle arrest (GO:0071156) | 2.98902596 |
111 | mitotic recombination (GO:0006312) | 2.98891590 |
112 | * negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.98463326 |
113 | * negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.98463326 |
114 | lactate metabolic process (GO:0006089) | 2.96889325 |
115 | mitotic sister chromatid segregation (GO:0000070) | 2.96538714 |
116 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.95568650 |
117 | oxidative phosphorylation (GO:0006119) | 2.95074225 |
118 | establishment of protein localization to mitochondrion (GO:0072655) | 2.94783361 |
119 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.92560307 |
120 | protein deneddylation (GO:0000338) | 2.91480475 |
121 | metaphase plate congression (GO:0051310) | 2.91469093 |
122 | establishment of viral latency (GO:0019043) | 2.90805323 |
123 | telomere maintenance via recombination (GO:0000722) | 2.90690447 |
124 | ncRNA 3-end processing (GO:0043628) | 2.90338112 |
125 | melanin biosynthetic process (GO:0042438) | 2.89366783 |
126 | establishment of integrated proviral latency (GO:0075713) | 2.87095313 |
127 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.86172306 |
128 | de novo protein folding (GO:0006458) | 2.84818580 |
129 | chaperone-mediated protein complex assembly (GO:0051131) | 2.84686386 |
130 | IMP metabolic process (GO:0046040) | 2.84088044 |
131 | tRNA aminoacylation for protein translation (GO:0006418) | 2.84078725 |
132 | histone arginine methylation (GO:0034969) | 2.83743166 |
133 | * regulation of ligase activity (GO:0051340) | 2.83194322 |
134 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.82527419 |
135 | tetrahydrofolate metabolic process (GO:0046653) | 2.82218492 |
136 | mitotic metaphase plate congression (GO:0007080) | 2.81994938 |
137 | UTP biosynthetic process (GO:0006228) | 2.80770359 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.16213657 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.53201119 |
3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.32410782 |
4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.18836370 |
5 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.16508658 |
6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.14266857 |
7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.08755959 |
8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.06334726 |
9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.03222506 |
10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.97916417 |
11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.93086558 |
12 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.81018927 |
13 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.58456512 |
14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.42415495 |
15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.39134086 |
16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38285136 |
17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.36555864 |
18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.36514590 |
19 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.25905311 |
20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25301139 |
21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.25037900 |
22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.24791100 |
23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.20871279 |
24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.12967423 |
25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08750162 |
26 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.00788155 |
27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.97946435 |
28 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.93093862 |
29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.81334198 |
30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80498703 |
31 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80160518 |
32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79072859 |
33 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.75927856 |
34 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.71916352 |
35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.70378181 |
36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70172191 |
37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68748041 |
38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67693684 |
39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.64680738 |
40 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.62958635 |
41 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61313424 |
42 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60110353 |
43 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58956875 |
44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56538540 |
45 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.56291127 |
46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55555251 |
47 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55178219 |
48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52518922 |
49 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.50640726 |
50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.48416508 |
51 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.47177246 |
52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42764802 |
53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.39869026 |
54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39312129 |
55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37020047 |
56 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.35234193 |
57 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34218244 |
58 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33283383 |
59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31916675 |
60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30235853 |
61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29764270 |
62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29754046 |
63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29150792 |
64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28494625 |
65 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.25330090 |
66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25195452 |
67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24096577 |
68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23724076 |
69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.23644017 |
70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23548881 |
71 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.21993733 |
72 | MYC_22102868_ChIP-Seq_BL_Human | 1.20354338 |
73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.19342949 |
74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19259609 |
75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18530166 |
76 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18346569 |
77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17047043 |
78 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.16995738 |
79 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16989660 |
80 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16751499 |
81 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16671515 |
82 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16633013 |
83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16392881 |
84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16094168 |
85 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.15097580 |
86 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.13416398 |
87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12986385 |
88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11429621 |
89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08769333 |
90 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08025297 |
91 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03841771 |
92 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.03341864 |
93 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03313463 |
94 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00091946 |
95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98869549 |
96 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.97483029 |
97 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.97132628 |
98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97085984 |
99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95680538 |
100 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94952661 |
101 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92915887 |
102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92903946 |
103 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92749013 |
104 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92698828 |
105 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90840279 |
106 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90087225 |
107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88748763 |
108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.88147685 |
109 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.87177044 |
110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86845072 |
111 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.86397383 |
112 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85787072 |
113 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85132211 |
114 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84014975 |
115 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.82755359 |
116 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.82489293 |
117 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80048092 |
118 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.77816588 |
119 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74833872 |
120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72787662 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 5.63244634 |
2 | MP0000372_irregular_coat_pigmentation | 4.85420628 |
3 | MP0004957_abnormal_blastocyst_morpholog | 4.69314027 |
4 | MP0003806_abnormal_nucleotide_metabolis | 3.69730526 |
5 | MP0003111_abnormal_nucleus_morphology | 3.60914203 |
6 | MP0005408_hypopigmentation | 3.59516963 |
7 | MP0003077_abnormal_cell_cycle | 3.32826290 |
8 | MP0009379_abnormal_foot_pigmentation | 3.26856498 |
9 | MP0005171_absent_coat_pigmentation | 3.14021871 |
10 | MP0010094_abnormal_chromosome_stability | 2.99635294 |
11 | MP0003136_yellow_coat_color | 2.94924037 |
12 | MP0005075_abnormal_melanosome_morpholog | 2.85945116 |
13 | MP0002938_white_spotting | 2.83176748 |
14 | MP0008932_abnormal_embryonic_tissue | 2.82198862 |
15 | MP0003186_abnormal_redox_activity | 2.49322698 |
16 | MP0003123_paternal_imprinting | 2.40268301 |
17 | MP0001730_embryonic_growth_arrest | 2.36926280 |
18 | MP0008058_abnormal_DNA_repair | 2.12561721 |
19 | MP0009840_abnormal_foam_cell | 2.12557821 |
20 | MP0000015_abnormal_ear_pigmentation | 2.04157412 |
21 | MP0006036_abnormal_mitochondrial_physio | 2.03726889 |
22 | MP0009697_abnormal_copulation | 1.94409438 |
23 | MP0010352_gastrointestinal_tract_polyps | 1.93858317 |
24 | MP0008007_abnormal_cellular_replicative | 1.85450309 |
25 | MP0000350_abnormal_cell_proliferation | 1.84267263 |
26 | MP0000358_abnormal_cell_content/ | 1.81513783 |
27 | MP0002139_abnormal_hepatobiliary_system | 1.76292087 |
28 | MP0003718_maternal_effect | 1.75727287 |
29 | MP0006035_abnormal_mitochondrial_morpho | 1.68373856 |
30 | MP0002095_abnormal_skin_pigmentation | 1.66897576 |
31 | MP0002102_abnormal_ear_morphology | 1.64087152 |
32 | MP0001697_abnormal_embryo_size | 1.63932647 |
33 | MP0002080_prenatal_lethality | 1.63503935 |
34 | MP0005174_abnormal_tail_pigmentation | 1.56922862 |
35 | MP0002163_abnormal_gland_morphology | 1.56755440 |
36 | MP0000750_abnormal_muscle_regeneration | 1.56734988 |
37 | MP0004381_abnormal_hair_follicle | 1.52259210 |
38 | MP0003705_abnormal_hypodermis_morpholog | 1.47508469 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.44190610 |
40 | MP0000537_abnormal_urethra_morphology | 1.43498638 |
41 | MP0001672_abnormal_embryogenesis/_devel | 1.42630487 |
42 | MP0005380_embryogenesis_phenotype | 1.42630487 |
43 | MP0000313_abnormal_cell_death | 1.37871768 |
44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.35944232 |
45 | MP0002090_abnormal_vision | 1.34233123 |
46 | MP0010234_abnormal_vibrissa_follicle | 1.34009172 |
47 | MP0000371_diluted_coat_color | 1.33117013 |
48 | MP0003786_premature_aging | 1.33030856 |
49 | MP0003119_abnormal_digestive_system | 1.31991029 |
50 | MP0004133_heterotaxia | 1.29849033 |
51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.29512494 |
52 | MP0003984_embryonic_growth_retardation | 1.28170802 |
53 | MP0002088_abnormal_embryonic_growth/wei | 1.28058439 |
54 | MP0003950_abnormal_plasma_membrane | 1.26925564 |
55 | MP0005379_endocrine/exocrine_gland_phen | 1.26114535 |
56 | MP0010030_abnormal_orbit_morphology | 1.24903921 |
57 | MP0002085_abnormal_embryonic_tissue | 1.23891375 |
58 | MP0001324_abnormal_eye_pigmentation | 1.23577790 |
59 | MP0002019_abnormal_tumor_incidence | 1.19561904 |
60 | MP0008877_abnormal_DNA_methylation | 1.18542925 |
61 | MP0000490_abnormal_crypts_of | 1.18424143 |
62 | MP0000858_altered_metastatic_potential | 1.17462982 |
63 | MP0002877_abnormal_melanocyte_morpholog | 1.16846367 |
64 | MP0009053_abnormal_anal_canal | 1.13452363 |
65 | MP0003941_abnormal_skin_development | 1.12024114 |
66 | MP0002084_abnormal_developmental_patter | 1.10675377 |
67 | MP0002086_abnormal_extraembryonic_tissu | 1.09878127 |
68 | MP0005360_urolithiasis | 1.09801175 |
69 | MP0001186_pigmentation_phenotype | 1.09471398 |
70 | MP0008057_abnormal_DNA_replication | 1.09102306 |
71 | MP0004197_abnormal_fetal_growth/weight/ | 1.09082539 |
72 | MP0005332_abnormal_amino_acid | 1.09000210 |
73 | MP0000647_abnormal_sebaceous_gland | 1.07771013 |
74 | MP0010307_abnormal_tumor_latency | 1.07584741 |
75 | MP0002075_abnormal_coat/hair_pigmentati | 1.03765271 |
76 | MP0005083_abnormal_biliary_tract | 1.02342340 |
77 | MP0008995_early_reproductive_senescence | 1.00249933 |
78 | MP0005319_abnormal_enzyme/_coenzyme | 0.99887199 |
79 | MP0003315_abnormal_perineum_morphology | 0.98203414 |
80 | MP0001764_abnormal_homeostasis | 0.96477953 |
81 | MP0005670_abnormal_white_adipose | 0.95176792 |
82 | MP0002751_abnormal_autonomic_nervous | 0.93846524 |
83 | MP0000598_abnormal_liver_morphology | 0.93262207 |
84 | MP0001661_extended_life_span | 0.93073667 |
85 | MP0002837_dystrophic_cardiac_calcinosis | 0.92838476 |
86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91635845 |
87 | MP0005501_abnormal_skin_physiology | 0.91206058 |
88 | MP0005023_abnormal_wound_healing | 0.90355886 |
89 | MP0009672_abnormal_birth_weight | 0.89424601 |
90 | MP0005085_abnormal_gallbladder_physiolo | 0.88300038 |
91 | MP0001293_anophthalmia | 0.85275320 |
92 | MP0001727_abnormal_embryo_implantation | 0.85077452 |
93 | MP0001853_heart_inflammation | 0.84322562 |
94 | MP0002254_reproductive_system_inflammat | 0.84248210 |
95 | MP0002111_abnormal_tail_morphology | 0.83990905 |
96 | MP0009643_abnormal_urine_homeostasis | 0.83021458 |
97 | MP0001881_abnormal_mammary_gland | 0.82742743 |
98 | MP0001929_abnormal_gametogenesis | 0.81950160 |
99 | MP0005266_abnormal_metabolism | 0.81528380 |
100 | MP0002160_abnormal_reproductive_system | 0.81114166 |
101 | MP0005384_cellular_phenotype | 0.80378383 |
102 | MP0005220_abnormal_exocrine_pancreas | 0.78212262 |
103 | MP0002269_muscular_atrophy | 0.77986822 |
104 | MP0005636_abnormal_mineral_homeostasis | 0.77857856 |
105 | MP0003656_abnormal_erythrocyte_physiolo | 0.77527202 |
106 | MP0002132_abnormal_respiratory_system | 0.77234309 |
107 | MP0005389_reproductive_system_phenotype | 0.77000033 |
108 | MP0003011_delayed_dark_adaptation | 0.76923380 |
109 | MP0000609_abnormal_liver_physiology | 0.76299690 |
110 | MP0003566_abnormal_cell_adhesion | 0.76135256 |
111 | MP0003195_calcinosis | 0.75731832 |
112 | MP0005330_cardiomyopathy | 0.75678040 |
113 | MP0000653_abnormal_sex_gland | 0.73575395 |
114 | MP0005197_abnormal_uvea_morphology | 0.73371383 |
115 | MP0005395_other_phenotype | 0.72115755 |
116 | MP0006054_spinal_hemorrhage | 0.71919478 |
117 | MP0002653_abnormal_ependyma_morphology | 0.71806207 |
118 | MP0000747_muscle_weakness | 0.71760105 |
119 | MP0002638_abnormal_pupillary_reflex | 0.71511749 |
120 | MP0004147_increased_porphyrin_level | 0.70571581 |
121 | MP0005084_abnormal_gallbladder_morpholo | 0.69648693 |
122 | MP0001919_abnormal_reproductive_system | 0.69562220 |
123 | MP0004185_abnormal_adipocyte_glucose | 0.69083546 |
124 | MP0001119_abnormal_female_reproductive | 0.65811783 |
125 | MP0001756_abnormal_urination | 0.65736425 |
126 | MP0002722_abnormal_immune_system | 0.64139700 |
127 | MP0001542_abnormal_bone_strength | 0.63928840 |
128 | MP0001145_abnormal_male_reproductive | 0.63840301 |
129 | MP0001529_abnormal_vocalization | 0.63701502 |
130 | MP0000477_abnormal_intestine_morphology | 0.62431986 |
131 | MP0002210_abnormal_sex_determination | 0.62398974 |
132 | MP0005621_abnormal_cell_physiology | 0.62367183 |
133 | MP0002396_abnormal_hematopoietic_system | 0.62129200 |
134 | MP0000749_muscle_degeneration | 0.61896665 |
135 | MP0001545_abnormal_hematopoietic_system | 0.60330503 |
136 | MP0005397_hematopoietic_system_phenotyp | 0.60330503 |
137 | MP0003646_muscle_fatigue | 0.59999045 |
138 | MP0000627_abnormal_mammary_gland | 0.59957841 |
139 | MP0000703_abnormal_thymus_morphology | 0.59836604 |
140 | MP0003878_abnormal_ear_physiology | 0.59574867 |
141 | MP0005377_hearing/vestibular/ear_phenot | 0.59574867 |
142 | MP0004019_abnormal_vitamin_homeostasis | 0.59533945 |
143 | MP0008260_abnormal_autophagy | 0.59389259 |
144 | MP0005076_abnormal_cell_differentiation | 0.59353905 |
145 | MP0001346_abnormal_lacrimal_gland | 0.58673799 |
146 | MP0006072_abnormal_retinal_apoptosis | 0.58058391 |
147 | MP0005257_abnormal_intraocular_pressure | 0.58048710 |
148 | MP0005253_abnormal_eye_physiology | 0.56690347 |
149 | MP0000689_abnormal_spleen_morphology | 0.56127245 |
150 | MP0000613_abnormal_salivary_gland | 0.55978723 |
151 | MP0003937_abnormal_limbs/digits/tail_de | 0.54694046 |
152 | MP0008873_increased_physiological_sensi | 0.53384948 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.54244709 |
2 | Reticulocytopenia (HP:0001896) | 5.06891276 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 5.03342763 |
4 | Macrocytic anemia (HP:0001972) | 4.38044937 |
5 | Multiple enchondromatosis (HP:0005701) | 3.98272796 |
6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.81587697 |
7 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.81587697 |
8 | Pallor (HP:0000980) | 3.76387945 |
9 | Hepatocellular necrosis (HP:0001404) | 3.54841208 |
10 | Acute necrotizing encephalopathy (HP:0006965) | 3.54213431 |
11 | Trismus (HP:0000211) | 3.52463065 |
12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.52081826 |
13 | Hepatic necrosis (HP:0002605) | 3.50241282 |
14 | Oral leukoplakia (HP:0002745) | 3.39829208 |
15 | Cerebral hypomyelination (HP:0006808) | 3.32690018 |
16 | Mitochondrial inheritance (HP:0001427) | 3.31881941 |
17 | Abnormality of the anterior horn cell (HP:0006802) | 3.26768612 |
18 | Degeneration of anterior horn cells (HP:0002398) | 3.26768612 |
19 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.24845635 |
20 | Breast hypoplasia (HP:0003187) | 3.24205948 |
21 | Renal Fanconi syndrome (HP:0001994) | 3.23998638 |
22 | Acute encephalopathy (HP:0006846) | 3.21560180 |
23 | Microretrognathia (HP:0000308) | 3.18923996 |
24 | Increased CSF lactate (HP:0002490) | 3.18178014 |
25 | Progressive muscle weakness (HP:0003323) | 3.12211636 |
26 | Patchy hypopigmentation of hair (HP:0011365) | 3.07720027 |
27 | Birth length less than 3rd percentile (HP:0003561) | 3.05540918 |
28 | Increased serum lactate (HP:0002151) | 3.02951929 |
29 | Type I transferrin isoform profile (HP:0003642) | 2.96823996 |
30 | Chromsome breakage (HP:0040012) | 2.86581258 |
31 | Rough bone trabeculation (HP:0100670) | 2.84019461 |
32 | Carpal bone hypoplasia (HP:0001498) | 2.83969692 |
33 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.79528293 |
34 | Colon cancer (HP:0003003) | 2.77459619 |
35 | Abnormality of glycolysis (HP:0004366) | 2.76202395 |
36 | Increased serum pyruvate (HP:0003542) | 2.76202395 |
37 | Cerebral edema (HP:0002181) | 2.73793863 |
38 | White forelock (HP:0002211) | 2.73379647 |
39 | Abnormality of the preputium (HP:0100587) | 2.70975074 |
40 | Hypoplasia of the fovea (HP:0007750) | 2.68737844 |
41 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.68737844 |
42 | Cholecystitis (HP:0001082) | 2.68108968 |
43 | Abnormal gallbladder physiology (HP:0012438) | 2.68108968 |
44 | Meckel diverticulum (HP:0002245) | 2.67999587 |
45 | Progressive macrocephaly (HP:0004481) | 2.64598747 |
46 | Abnormality of methionine metabolism (HP:0010901) | 2.64581038 |
47 | CNS demyelination (HP:0007305) | 2.63551776 |
48 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.63333522 |
49 | Respiratory failure (HP:0002878) | 2.62993876 |
50 | Angiofibromas (HP:0010615) | 2.60849007 |
51 | Adenoma sebaceum (HP:0009720) | 2.60849007 |
52 | Lactic acidosis (HP:0003128) | 2.56460676 |
53 | Abnormal hemoglobin (HP:0011902) | 2.55935586 |
54 | Leukodystrophy (HP:0002415) | 2.54900243 |
55 | Abnormality of reticulocytes (HP:0004312) | 2.54897697 |
56 | Secondary amenorrhea (HP:0000869) | 2.54795628 |
57 | Premature ovarian failure (HP:0008209) | 2.52571429 |
58 | Abnormality of the ileum (HP:0001549) | 2.51982903 |
59 | Hypokinesia (HP:0002375) | 2.51515963 |
60 | Hypobetalipoproteinemia (HP:0003563) | 2.48627926 |
61 | Emotional lability (HP:0000712) | 2.47386428 |
62 | Neoplasm of the adrenal gland (HP:0100631) | 2.37442555 |
63 | Increased hepatocellular lipid droplets (HP:0006565) | 2.35385164 |
64 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.35176632 |
65 | Abnormality of the fovea (HP:0000493) | 2.35031910 |
66 | Lipid accumulation in hepatocytes (HP:0006561) | 2.34663346 |
67 | Nausea (HP:0002018) | 2.34323911 |
68 | Optic disc pallor (HP:0000543) | 2.33926794 |
69 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33889166 |
70 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33889166 |
71 | Abnormal protein glycosylation (HP:0012346) | 2.33889166 |
72 | Abnormal glycosylation (HP:0012345) | 2.33889166 |
73 | Ependymoma (HP:0002888) | 2.33455467 |
74 | Cutaneous melanoma (HP:0012056) | 2.31634909 |
75 | Respiratory difficulties (HP:0002880) | 2.30304564 |
76 | Exercise intolerance (HP:0003546) | 2.29709389 |
77 | Increased intramyocellular lipid droplets (HP:0012240) | 2.26692883 |
78 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26491805 |
79 | Neoplasm of the pancreas (HP:0002894) | 2.26111945 |
80 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25776839 |
81 | Aplastic anemia (HP:0001915) | 2.24529851 |
82 | Megaloblastic anemia (HP:0001889) | 2.21536687 |
83 | Microvesicular hepatic steatosis (HP:0001414) | 2.20399612 |
84 | Hyperglycinemia (HP:0002154) | 2.20396188 |
85 | Sensory axonal neuropathy (HP:0003390) | 2.19708519 |
86 | Absent thumb (HP:0009777) | 2.19096885 |
87 | Lethargy (HP:0001254) | 2.17793778 |
88 | Pancytopenia (HP:0001876) | 2.15610009 |
89 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.15364591 |
90 | Ragged-red muscle fibers (HP:0003200) | 2.15217664 |
91 | Increased muscle lipid content (HP:0009058) | 2.15096022 |
92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13899073 |
93 | Reduced antithrombin III activity (HP:0001976) | 2.13533037 |
94 | Selective tooth agenesis (HP:0001592) | 2.11709559 |
95 | Abnormality of chromosome stability (HP:0003220) | 2.10169774 |
96 | Horseshoe kidney (HP:0000085) | 2.10008786 |
97 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.08838062 |
98 | Poor head control (HP:0002421) | 2.07668895 |
99 | Spastic paraparesis (HP:0002313) | 2.07230079 |
100 | Breast carcinoma (HP:0003002) | 2.04491808 |
101 | Rhabdomyolysis (HP:0003201) | 2.02776516 |
102 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.98335886 |
103 | Abnormal trabecular bone morphology (HP:0100671) | 1.92943638 |
104 | Testicular atrophy (HP:0000029) | 1.92752659 |
105 | Abnormal cartilage morphology (HP:0002763) | 1.92457514 |
106 | Small intestinal stenosis (HP:0012848) | 1.91924852 |
107 | Duodenal stenosis (HP:0100867) | 1.91924852 |
108 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.90416216 |
109 | Abnormality of the labia minora (HP:0012880) | 1.90347834 |
110 | CNS hypomyelination (HP:0003429) | 1.89768985 |
111 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.89071742 |
112 | Hyperglycinuria (HP:0003108) | 1.88003471 |
113 | Sparse eyelashes (HP:0000653) | 1.87253930 |
114 | Abnormality of renal resorption (HP:0011038) | 1.87047126 |
115 | Abnormality of the umbilical cord (HP:0010881) | 1.86870319 |
116 | Achilles tendon contracture (HP:0001771) | 1.86785150 |
117 | Posterior subcapsular cataract (HP:0007787) | 1.86295444 |
118 | Glossoptosis (HP:0000162) | 1.85258861 |
119 | Patellar aplasia (HP:0006443) | 1.85255134 |
120 | Postnatal microcephaly (HP:0005484) | 1.84618110 |
121 | Conjunctival hamartoma (HP:0100780) | 1.84132033 |
122 | Hypoglycemic coma (HP:0001325) | 1.84122565 |
123 | Adrenal hypoplasia (HP:0000835) | 1.83766357 |
124 | Abnormality of serum amino acid levels (HP:0003112) | 1.83287600 |
125 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83219990 |
126 | Abnormality of the Achilles tendon (HP:0005109) | 1.83051545 |
127 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.82907022 |
128 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.80511990 |
129 | Abnormal lung lobation (HP:0002101) | 1.80361201 |
130 | Cleft eyelid (HP:0000625) | 1.78845961 |
131 | Spastic diplegia (HP:0001264) | 1.78735652 |
132 | Increased serum ferritin (HP:0003281) | 1.77837351 |
133 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.76575510 |
134 | Albinism (HP:0001022) | 1.76346015 |
135 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76146516 |
136 | Dicarboxylic aciduria (HP:0003215) | 1.76146516 |
137 | Hyperammonemia (HP:0001987) | 1.75658005 |
138 | Myelodysplasia (HP:0002863) | 1.75478395 |
139 | Personality changes (HP:0000751) | 1.74897329 |
140 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.74467099 |
141 | Abnormality of alanine metabolism (HP:0010916) | 1.74467099 |
142 | Hyperalaninemia (HP:0003348) | 1.74467099 |
143 | Exertional dyspnea (HP:0002875) | 1.74253717 |
144 | Cellular immunodeficiency (HP:0005374) | 1.71710914 |
145 | Delusions (HP:0000746) | 1.71396559 |
146 | Death in infancy (HP:0001522) | 1.70037910 |
147 | Overlapping toe (HP:0001845) | 1.68832765 |
148 | Premature graying of hair (HP:0002216) | 1.68444798 |
149 | Abnormality of glycine metabolism (HP:0010895) | 1.68318769 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 5.20930593 |
2 | BUB1 | 4.79752979 |
3 | VRK2 | 4.47390356 |
4 | WEE1 | 3.47913629 |
5 | EIF2AK1 | 3.37889013 |
6 | TLK1 | 3.27682477 |
7 | TESK2 | 3.05247553 |
8 | TRIM28 | 2.98955338 |
9 | STK16 | 2.38457448 |
10 | BCKDK | 2.33689019 |
11 | SIK3 | 2.08200599 |
12 | CDC7 | 1.95235571 |
13 | MKNK2 | 1.90336487 |
14 | MAP3K11 | 1.89752602 |
15 | NUAK1 | 1.89511561 |
16 | TESK1 | 1.88938427 |
17 | EPHA2 | 1.86401351 |
18 | PDK2 | 1.80870279 |
19 | DYRK3 | 1.80661061 |
20 | SRPK1 | 1.80181213 |
21 | SCYL2 | 1.78042512 |
22 | MAP3K12 | 1.76652062 |
23 | RPS6KA4 | 1.75629378 |
24 | PASK | 1.75114544 |
25 | NEK1 | 1.75049534 |
26 | NEK2 | 1.72358204 |
27 | TAF1 | 1.71348149 |
28 | KDR | 1.56502489 |
29 | AURKA | 1.51312767 |
30 | NME1 | 1.50161342 |
31 | ACVR1B | 1.49645197 |
32 | PKN2 | 1.48211884 |
33 | TTK | 1.46090299 |
34 | PIM2 | 1.44480506 |
35 | EIF2AK3 | 1.43872532 |
36 | PAK4 | 1.42567327 |
37 | RPS6KB2 | 1.40570287 |
38 | PLK1 | 1.37285530 |
39 | MAP3K8 | 1.36941120 |
40 | BRAF | 1.32064601 |
41 | LIMK1 | 1.31436837 |
42 | LRRK2 | 1.31209716 |
43 | TRIB3 | 1.28918248 |
44 | AURKB | 1.25441861 |
45 | TSSK6 | 1.21451205 |
46 | VRK1 | 1.19830787 |
47 | PLK4 | 1.19368015 |
48 | ERBB3 | 1.18395854 |
49 | BLK | 1.16323122 |
50 | TGFBR1 | 1.12906402 |
51 | EIF2AK2 | 1.07869467 |
52 | ARAF | 1.04658929 |
53 | CDK7 | 1.02860324 |
54 | FLT3 | 1.02538985 |
55 | LATS2 | 1.02106361 |
56 | BRSK2 | 1.00524807 |
57 | SMG1 | 0.99912304 |
58 | DAPK1 | 0.97480728 |
59 | PAK1 | 0.97101503 |
60 | ERN1 | 0.96909249 |
61 | ABL2 | 0.96148392 |
62 | MAP3K10 | 0.95951084 |
63 | BCR | 0.91121315 |
64 | ILK | 0.88983726 |
65 | PLK2 | 0.86923494 |
66 | BMPR1B | 0.85533860 |
67 | MAPKAPK3 | 0.84123771 |
68 | CDK4 | 0.83108702 |
69 | IRAK3 | 0.82597437 |
70 | CCNB1 | 0.79124046 |
71 | MAP2K2 | 0.78492518 |
72 | CSNK1G1 | 0.77265685 |
73 | DAPK3 | 0.77180956 |
74 | PBK | 0.75288275 |
75 | PLK3 | 0.75191230 |
76 | CHEK2 | 0.73842746 |
77 | PRKCI | 0.71204458 |
78 | CSNK2A2 | 0.70543328 |
79 | DYRK2 | 0.69948720 |
80 | MAP2K3 | 0.69883268 |
81 | NEK9 | 0.69765980 |
82 | ZAP70 | 0.69292962 |
83 | BRSK1 | 0.65205118 |
84 | ZAK | 0.65104971 |
85 | ATR | 0.63192505 |
86 | CSNK2A1 | 0.62418647 |
87 | CSNK1G2 | 0.62028728 |
88 | STK4 | 0.61856963 |
89 | FER | 0.61365977 |
90 | RPS6KA5 | 0.60492342 |
91 | CSNK1A1L | 0.58313964 |
92 | PIM1 | 0.54477375 |
93 | ALK | 0.52789992 |
94 | EEF2K | 0.50838897 |
95 | CHEK1 | 0.50568801 |
96 | GRK6 | 0.50065493 |
97 | GRK1 | 0.45983067 |
98 | STK10 | 0.45886383 |
99 | MAP4K2 | 0.44917992 |
100 | CDK19 | 0.44178266 |
101 | MAPKAPK5 | 0.44041382 |
102 | ERBB4 | 0.43676725 |
103 | MST4 | 0.42181645 |
104 | WNK3 | 0.42170211 |
105 | STK3 | 0.41152175 |
106 | MKNK1 | 0.39890962 |
107 | ATM | 0.39773990 |
108 | CDK2 | 0.38637269 |
109 | MUSK | 0.38379102 |
110 | DYRK1B | 0.37351233 |
111 | TNIK | 0.37154553 |
112 | STK39 | 0.36043616 |
113 | PAK3 | 0.35968130 |
114 | PDK3 | 0.34379089 |
115 | PDK4 | 0.34379089 |
116 | MAP3K3 | 0.34020109 |
117 | CSNK1E | 0.32515567 |
118 | AKT2 | 0.32422985 |
119 | MAP4K1 | 0.31885120 |
120 | MST1R | 0.31685747 |
121 | MINK1 | 0.30054863 |
122 | CLK1 | 0.29545455 |
123 | TTN | 0.28767009 |
124 | MET | 0.28235010 |
125 | OXSR1 | 0.28226835 |
126 | MYLK | 0.28146415 |
127 | FGFR1 | 0.28142378 |
128 | CDK8 | 0.27528161 |
129 | MAP3K5 | 0.27516991 |
130 | CSNK1G3 | 0.26901863 |
131 | STK38L | 0.26434787 |
132 | FRK | 0.25737118 |
133 | CDK14 | 0.23654977 |
134 | MOS | 0.23437393 |
135 | PAK2 | 0.23420617 |
136 | MARK3 | 0.22814898 |
137 | RPS6KA1 | 0.22323286 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 5.37861439 |
2 | * Proteasome_Homo sapiens_hsa03050 | 4.33828070 |
3 | DNA replication_Homo sapiens_hsa03030 | 3.77111235 |
4 | RNA polymerase_Homo sapiens_hsa03020 | 3.09443028 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 2.96815552 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.77582370 |
7 | Spliceosome_Homo sapiens_hsa03040 | 2.72794597 |
8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.44096686 |
9 | RNA transport_Homo sapiens_hsa03013 | 2.40452883 |
10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.40392162 |
11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.33919769 |
12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.21718434 |
13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.13583818 |
14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13184969 |
15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.13164012 |
16 | Base excision repair_Homo sapiens_hsa03410 | 2.10334963 |
17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94465499 |
18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90956472 |
19 | Homologous recombination_Homo sapiens_hsa03440 | 1.87048901 |
20 | Protein export_Homo sapiens_hsa03060 | 1.74656458 |
21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.63793598 |
22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48048109 |
23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46725383 |
24 | Cell cycle_Homo sapiens_hsa04110 | 1.41754724 |
25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36921756 |
26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.36614632 |
27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35246660 |
28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34688655 |
29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.33711854 |
30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29947997 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28893757 |
32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20510185 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17433165 |
34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16926915 |
35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15058056 |
36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13289517 |
37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08429946 |
38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04634522 |
39 | Purine metabolism_Homo sapiens_hsa00230 | 1.03968664 |
40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.99537683 |
41 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99395098 |
42 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99198193 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96631200 |
44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93822982 |
45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91499326 |
46 | RNA degradation_Homo sapiens_hsa03018 | 0.88664536 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87856037 |
48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87788810 |
49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87650094 |
50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82059769 |
51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81393242 |
52 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.80260051 |
53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75228064 |
54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74780054 |
55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.74477770 |
56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73214458 |
57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70950046 |
58 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67734355 |
59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63384718 |
60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62923813 |
61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62907393 |
62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61653980 |
63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60852395 |
64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60061769 |
65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59274494 |
66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58142681 |
67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56447802 |
68 | Bladder cancer_Homo sapiens_hsa05219 | 0.53461284 |
69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52459409 |
70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52278547 |
71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51408409 |
72 | Legionellosis_Homo sapiens_hsa05134 | 0.50843313 |
73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50702214 |
74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48684951 |
75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48644467 |
76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48111943 |
77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45871577 |
78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45311971 |
79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45215914 |
80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44169081 |
81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43905854 |
82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43783299 |
83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42089174 |
84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41703510 |
85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41411342 |
86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39973715 |
87 | Peroxisome_Homo sapiens_hsa04146 | 0.39243624 |
88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37151956 |
89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34322522 |
90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34314479 |
91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33958272 |
92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31481018 |
93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30305411 |
94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.28220407 |
95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27973363 |
96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27663724 |
97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26835582 |
98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26832458 |
99 | Alcoholism_Homo sapiens_hsa05034 | 0.26250371 |
100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26214613 |
101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25806314 |
102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.24499381 |
103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23774697 |
104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23669075 |
105 | Shigellosis_Homo sapiens_hsa05131 | 0.23594913 |
106 | Apoptosis_Homo sapiens_hsa04210 | 0.23026057 |
107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22864820 |
108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21935790 |
109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21452969 |
110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.21416371 |
111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14727626 |
112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.12585071 |
113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.11477596 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.11080139 |
115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.09627485 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.08961446 |
117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.08927454 |
118 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.08906081 |